Stock report · Delisted · Nasdaq
MEI Pharma Inc (MEIP)
3.07USD Delisted Final close · Sep 10, 2025
MEIP no longer trades. MEI Pharma was delisted from the Nasdaq in September 2025.
All prices on this page are historical. The last trade was on September 10, 2025, at $3.07.
MEIP stock price history
Final trading statistics
- Final close
- $3.07
- Final trading day
- Sep 10, 2025
- Market cap at delisting
- $100.81M
- Shares outstanding
- 32.84M
- Final 52-week range
- $1.46 – $9.00
- Avg. volume (final 3 mo.)
- 1,434,193
- All-time high
- $11903.46 · Feb 2004
- All-time low
- $1.86 · Apr 2025
- Return since IPO
- -100.0%
- Beta
- 0.22
- Book value / share
- $2.93
- Price / book
- 1.05
About MEI Pharma Inc
MEI Pharma, Inc. was a clinical-stage drug company working on cancer therapies. Its candidate ME-344 was an intravenous small molecule that blocks mitochondrial oxidative phosphorylation, studied in HER2-negative breast cancer, colorectal cancer and solid tumors. Known as Marshall Edwards, Inc. until July 2012, it was incorporated in 2000 and based in San Diego. Its stock was delisted from the Nasdaq in September 2025, with a final trade on September 10, 2025 at $3.07.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- San Diego, CA
- Employees
- 28
- IPO date
- December 19, 2003
- Delisted
- September 10, 2025
- SEC CIK
- 1262104
MEI Pharma financials before the delisting
The last 5 fiscal years MEI Pharma reported as a public company, fiscal year ending June.
MEIP revenue and net income
MEIP earnings per share
MEIP annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0.00 | −$15.9M | — |
| FY2024 | $65.30M | $17.8M | $2.67 |
| FY2023 | $48.82M | −$31.8M | −$3.87 |
| FY2022 | $40.70M | −$54.5M | −$0.35 |
| FY2021 | $25.54M | −$41.3M | −$0.45 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
MEI Pharma stock FAQ
What happened to MEI Pharma stock?
MEI Pharma was delisted from the Nasdaq in September 2025. The final close was $3.07 on September 10, 2025.
Can I still buy MEIP stock?
No. MEIP is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on September 10, 2025.
What was the last price of MEIP?
MEIP last closed at $3.07 on September 10, 2025, which valued the company at about $100.81M.
How did MEI Pharma do in its last full fiscal year?
In fiscal 2025, its last full year as a public company, MEI Pharma reported revenue of $0.00 and net income of −$15.9M.
When did MEI Pharma go public?
MEI Pharma shares started trading on December 19, 2003.
MEIP no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.